Tamibarotene (OAM80)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tamibarotene (OAM80), covering 2011-07-22 to 2011-07-22. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease [Phase 2]